Targeting Oxidative Stress With Auranofin or Prima-1
APR-246
Prima-1Met
ROS
auranofin
venetoclax
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2019
2019
Historique:
received:
09
11
2018
accepted:
13
02
2019
entrez:
22
3
2019
pubmed:
22
3
2019
medline:
22
3
2019
Statut:
epublish
Résumé
Prima-1
Identifiants
pubmed: 30895171
doi: 10.3389/fonc.2019.00128
pmc: PMC6414792
doi:
Types de publication
Journal Article
Langues
eng
Pagination
128Références
Cancer Cell. 2009 May 5;15(5):376-88
pubmed: 19411067
Haematologica. 2010 Nov;95(11):1973-6
pubmed: 20634494
Haematologica. 2011 Apr;96(4):574-82
pubmed: 21173094
Cancer Res. 2012 Sep 1;72(17):4562-73
pubmed: 22738917
Cell Death Differ. 2013 Jul;20(7):898-909
pubmed: 23538418
Cell Death Dis. 2013 Oct 24;4:e881
pubmed: 24157875
Sci Rep. 2014 Feb 27;4:4223
pubmed: 24573247
BMC Cancer. 2014 Jun 14;14:437
pubmed: 24927749
Blood. 2014 Sep 4;124(10):1626-36
pubmed: 25006124
Cytometry A. 2015 Apr;87(4):285-8
pubmed: 25688540
Nat Chem Biol. 2016 Jan;12(1):22-8
pubmed: 26595461
Br J Haematol. 2017 Nov;179(4):684-688
pubmed: 27471002
Blood Rev. 2017 Jul;31(4):251-259
pubmed: 28284458
Nat Commun. 2017 Mar 28;8:14844
pubmed: 28348409
Blood. 2017 Oct 26;130(17):1903-1910
pubmed: 28819011
Nat Rev Cancer. 2018 Feb;18(2):89-102
pubmed: 29242642
Cell Death Dis. 2018 Jan 24;9(2):89
pubmed: 29367724
Cell Death Dis. 2018 Apr 18;9(5):439
pubmed: 29670092
Leukemia. 2019 Jan;33(1):159-170
pubmed: 29967379
Cell Chem Biol. 2018 Oct 18;25(10):1219-1230.e3
pubmed: 30057300
Mol Cancer Ther. 2018 Oct;17(10):2156-2163
pubmed: 30065099
Blood. 2018 Dec 20;132(25):2656-2669
pubmed: 30309889
Blood Adv. 2018 Dec 11;2(23):3492-3505
pubmed: 30530776
J Hematol Oncol. 2018 Dec 13;11(1):137
pubmed: 30545397